Results 141 to 150 of about 14,200 (285)

Successful treatment of therapy-resistant metastatic Crohn's desiase with infliximab [PDF]

open access: yes, 2004
CASTIGLIONE, FABIANA   +5 more
core   +1 more source

Mesalamine: Safe at first look [PDF]

open access: yesInflammatory Bowel Diseases, 1999
L J, Saubermann, J L, Wolf
openaire   +2 more sources

Striking elevation in the incidence and prevalence of inflammatory bowel disease in a province of Western Hungary between 1977-2001 [PDF]

open access: yes, 2004
AIM: An investigation into inflammatory bowel disease and colorectal cancer in Veszprem Province was conducted from 1977 to 2001. METHODS: Both hospital and outpatient records were collected and reviewed comprehensively.
Balogh, Mihály   +6 more
core  

Endoscopically measured mucosal healing of delayed-release oral mesalamine 4.8 g/day versus 2.4 g/day [PDF]

open access: bronze, 2007
Gary R. Lichtenstein   +3 more
openalex   +1 more source

UEG Week 2025 Oral Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S7-S188, October 2025.
wiley   +1 more source

Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease [PDF]

open access: yes, 2007
Avellini, Claudio   +3 more
core   +1 more source

The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcerative Colitis [PDF]

open access: bronze, 2013
Brian G. Feagan   +22 more
openalex   +1 more source

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice [PDF]

open access: green, 2021
David M. Alvarado   +5 more
openalex   +1 more source

Effects of Mesalamine Treatment on Gut Barrier Integrity After Burn Injury

open access: green, 2016
Abigail R. Cannon   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy